Portal Vein Thrombosis Clinical Trial
Official title:
Follow-up and Survival of Cirrhotic and Non Cirrhotic Patients With Portal Vein Thrombosis Treated With Transjugular Intrahepatic Portosystemic Shunt
Portal vein thrombosis (PVT) is defined as an obstruction of the portal vein. The prevalence
of PVT is 10-25% and incidence is about 16% in cirrhotic patients. PVT leads to increased
intrahepatic resistance, decreased portal velocities, splanchnic vasodilatation, and stagnant
flow.
Portal vein recanalization (PVR) with transjugular intrahepatic portosystemic shunt (TIPS) is
aimed at restoring main portal vein (PV) flow in chronic PVT. In this study, we will review
the safety and outcomes of this approach.
Portal vein thrombosis (PVT) is a fairly common complication of liver cirrhosis. Importantly, occlusive PVT might influence the prognosis of patients with cirrhosis. Transjugular intrahepatic portosystemic shunt (TIPS) has been reported to be an effective treatment of PVT in cirrhosis, with the advantage of avoiding the risk of bleeding linked to anticoagulation. In this study, we will evaluate the outcome of TIPS for PVT in patients with and without cirrhosis and determinate survival. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT03631147 -
The Effect of Rifaximin on Portal Vein Thrombosis
|
N/A | |
| Completed |
NCT02250391 -
Placebo-controlled Study of NPB-06 in Patients With Portal Vein Thrombosis
|
Phase 3 | |
| Recruiting |
NCT05625893 -
Proton Beam Radiotherapy Followed by Tecentriq and Avastin for Primary Liver Cancer With Vp2-4 Portal Vein Invasion
|
Phase 2 | |
| Completed |
NCT05012501 -
Analysis of Neutrophil Extracellular Traps in Hypercoagulability and Portal Vein Thrombosis in Liver Cirrhosis Patients
|
||
| Terminated |
NCT00769873 -
Anticoagulation Post Laparoscopic Splenectomy
|
Phase 2 | |
| Recruiting |
NCT05123326 -
Global Coagulation Assessment in Portal Vein Thrombosis and Budd-Chiari Syndrome
|
||
| Completed |
NCT01095185 -
Efficacy of Statin Association With Standard Treatment in Prevention of Recurrent Hemorrhage in Patient With Cirrhosis and Variceal Bleeding
|
Phase 3 | |
| Completed |
NCT02585713 -
Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism
|
Phase 3 | |
| Not yet recruiting |
NCT06117488 -
Risk Factors and Management Outcome of Chronic Portal Vein Thrombosis in Children
|
||
| Completed |
NCT01326949 -
Transjugular Intrahepatic Portosystemic Shunt (TIPS) for Prevention of Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis
|
N/A | |
| Not yet recruiting |
NCT05339581 -
IMRT Plus PD-1 Blockade and Lenvatinib for HCC With PVTT (Vp3) Before Liver Transplantation
|
N/A | |
| Recruiting |
NCT03902678 -
Role of EUS Guided FNA of Portal Vein Thrombus in the Diagnosis and Staging of Hepatocellular Carcinoma
|
N/A | |
| Not yet recruiting |
NCT06319131 -
Nadroparin Versus TIPS in Cirrhotic Patients With Refractory Asymptomatic PVT
|
N/A | |
| Recruiting |
NCT03193502 -
Efficacy and Safety of Rivaroxaban in the Management of Acute Non-neoplastic PVT Compensated Cirrhosis
|
Phase 3 | |
| Completed |
NCT03201367 -
Efficacy and Safety of Rivaroxaban in Acute Non-neoplastic Portal Vein Thrombosis in HCV
|
N/A | |
| Completed |
NCT03477149 -
EASYX-1 : A Multicenter Study on Safety and Efficacy of Easyx Liquid Embolization Agent Used in Five Separate Indications
|
N/A | |
| Recruiting |
NCT02398357 -
The Effect of Anticoagulation After Endoscopic Therapy in Cirrhotic Patients With Portal Vein Thrombosis
|
Phase 4 | |
| Completed |
NCT01556282 -
TheraSpheres Treatment for Unresectable Hepatocarcinoma and Portal Vein Thrombosis
|
N/A | |
| Withdrawn |
NCT01631877 -
Efficacy and Safety of Acenocoumarol for Treatment of Nontumor Portal Vein Thrombosis in Cirrhosis of Liver
|
N/A | |
| Recruiting |
NCT04433481 -
Efficacy and Safety of Dabigatran in Patients With Cirrhosis and Portal Vein Thrombosis
|
N/A |